RecruitingPhase 3NCT04374799

Heparin vs Placebo for Cardiac Catheterization

A Randomized Trial of Heparin vs Placebo in Patients Undergoing Cardiac Catheterization Via the Trans-radial Approach

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Enrollment

1,623 participants

Start Date

Oct 5, 2020

Study Type

INTERVENTIONAL

Conditions

Cardiac Disease

Summary

Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Heparin and a drug called Placebos for people with cardiac disease. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHeparin

two doses of heparin

DRUGPlacebos

placebo

Locations(2)

Hamilton Health Sciences

Hamilton, Ontario, Canada

London Health Sciences Centre

London, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04374799

Related Trials

BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES)

NCT0482366326 locations

Dynamic Cardio-vascular, Cerebro-vascular and Cortical Interaction in Healthy Adult Subjects

NCT067851811 location